Found 52 matching trials
Phase 3 Pivotal Trial of NanoFlu™ in Older Adults PHASE3 A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Show More Learn More & Join Trial
Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine PHASE2 The main purpose of this Phase II study was to assess the safety and immuno...
Show More Location
Investigational Site Number :8400003
Learn More & Join Trial
Immunogenicity Trial of 3 Influenza Vaccines PHASE3 This study is a prospective randomised trial of 3 influenza vaccine formula...
Show More Location
National Centre for Infectious Diseases (NCID)
Learn More & Join Trial
Recombinant Influenza Vaccination in U.S. Nursing Homes PHASE4 Based on recent evidence on the mutation of the A/H3N2 strain in egg-grown ...
Show More Location
Insight Therapeutics, LLC
Learn More & Join Trial
Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. PHASE3 Multicentric study, Phase III; this study is a randomized, participant- and...
Show More Location
Clinical Research Institute Saltillo
Learn More & Join Trial
Senescent Immunity in Elders and Vaccine Responses (SILVER) PHASE4 To study the effects of age on the immune system's response to flu vaccine ...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older PHASE1 The purpose of this study is to evaluate the safety and immunogenicity of a...
Show More Location
Peninsula Research Associates Site Number : 8400013
Learn More & Join Trial
Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects PHASE1 The primary objectives of the study are:
* To describe the safety profile ...
Show More Location
Investigational Site Number 8400003
Learn More & Join Trial
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years PHASE1 One dose of escalating strengths of an investigational influenza vaccine, V...
Show More Location
Q-Pharm Pty Limited
Learn More & Join Trial
Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years PHASE2 This is a multi-center, randomized, double-blind, active comparator control...
Show More Learn More & Join Trial